Giffin Brett A.

CIK 00018929211 companyLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001892921

Recent Transactions

18 trades

Award
T2 Biosystems, Inc.
Restricted Stock Units
2024-11-04+180,000→ 180,000 total
Award
T2 Biosystems, Inc.
Restricted Stock Units
2024-11-04+180,000→ 180,000 total
Exercise/Conversion
T2 Biosystems, Inc.
Common Stock
2024-02-20+13→ 77 total
Award
T2 Biosystems, Inc.
Restricted Stock Units
2024-02-20+13→ 13 total
Exercise/Conversion
T2 Biosystems, Inc.
Restricted Stock Units
2023-11-08−33→ 34 total
Exercise/Conversion
T2 Biosystems, Inc.
Common Stock
2023-11-08+33→ 64 total
Sale
T2 Biosystems, Inc.
Common Stock
2023-02-22$0.65/sh−537→ 841 total
Exercise/Conversion
T2 Biosystems, Inc.
Restricted Stock Units
2023-02-20−1,333→ 2,667 total
Exercise/Conversion
T2 Biosystems, Inc.
Common Stock
2023-02-20+1,333→ 3,586 total
Exercise/Conversion
T2 Biosystems, Inc.
Common Stock
2023-02-20+1,333→ 1,378 total
Exercise/Conversion
T2 Biosystems, Inc.
Restricted Stock Units
2023-02-20−1,333→ 2,667 total
Sale
T2 Biosystems, Inc.
Common Stock
2023-02-20$0.65/sh−537→ 3,049 total
Sale
T2 Biosystems, Inc.
Common Stock
2022-11-10$1.79/sh−1,292→ 2,253 total
Exercise/Conversion
T2 Biosystems, Inc.
Common Stock
2022-11-08+3,333→ 3,545 total
Exercise/Conversion
T2 Biosystems, Inc.
Restricted Stock Units
2022-11-08−3,333→ 6,667 total
Purchase
T2 Biosystems, Inc.
Common Stock
2022-04-08$0.49/sh+10,600→ 10,600 total
Award
T2 Biosystems, Inc.
Restricted Stock Units
2022-02-26+500,000→ 500,000 total
Award
T2 Biosystems, Inc.
Restricted Stock Units
2022-02-20+200,000→ 200,000 total

Companies

T2 Biosystems, Inc.
Chief Commercial Officer

Recent Filings

Address

101 HARTWELL AVENUE

LEXINGTON, MA, 02421

View on SEC.gov